Is Early Ischemic Lesion Volume on Diffusion-Weighted Imaging an Independent Predictor of Stroke Outcome?: A Multivariable Analysis

Background and Purpose The heterogeneity of stroke makes outcome prediction difficult. Neuroimaging parameters may improve the predictive value of clinical measures such as the National Institutes of Health Stroke Scale (NIHSS). We investigated whether the volume of early ischemic brain lesions assessed with diffusion-weighted imaging (DWI) was an independent predictor of functional outcome. Methods We retrospectively selected patients with nonlacunar ischemic stroke in the anterior circulation from 4 prospective Stanford Stroke Center studies evaluating early MRI. The baseline NIHSS score and ischemic stroke risk factors were assessed. A DWI MRI was performed within 48 hours of symptom onset. Clinical characteristics and early lesion volume on DWI were compared between patients with an independent outcome (Barthel Index score ≥85) and a dependent outcome (Barthel Index score <85) at 1 month. A logistic regression model was performed with factors that were significantly different between the 2 groups in univariate analysis. Results Sixty-three patients fulfilled the entry criteria. One month after symptom onset, 24 patients had a Barthel Index score <85 and 39 had a Barthel Index score ≥85. In univariate analysis, patients with independent outcome were younger, had lower baseline NIHSS scores, and had smaller lesion volumes on DWI. In a logistic regression model, DWI volume was an independent predictor of outcome, together with age and NIHSS score, after correction for imbalances in the delay between symptom onset and MRI. Conclusions DWI lesion volume measured within 48 hours of symptom onset is an independent risk factor for functional independence. This finding could have implications for the design of acute stroke trials.

[1]  W. Koroshetz,et al.  Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS Investigators. , 1999, Stroke.

[2]  N. Wahlgren,et al.  Clomethiazole Acute Stroke Study (CLASS) Results of a Randomized, Controlled Trial of Clomethiazole Versus Placebo in 1360 Acute Stroke Patients , 1998 .

[3]  E. Tolosa,et al.  Early prediction of stroke severity. Role of the erythrocyte sedimentation rate. , 1995, Stroke.

[4]  Xin Qun Wang,et al.  A predictive risk model for outcomes of ischemic stroke. , 2000, Stroke.

[5]  T. Brott,et al.  Improved Reliability of the NIH Stroke Scale Using Video Training , 1994, Stroke.

[6]  M. Cowan,et al.  American Heart Association. , 2018, P & T : a peer-reviewed journal for formulary management.

[7]  M. Naeser,et al.  Quantitative CT scan studies in aphasia I. Infarct size and CT numbers , 1981, Brain and Language.

[8]  B. Cesana,et al.  Prognostic Factors in First‐Ever Stroke in the Carotid Artery Territory Seen Within 6 Hours After Onset , 1993, Stroke.

[9]  L H Schwamm,et al.  Time course of lesion development in patients with acute stroke: serial diffusion- and hemodynamic-weighted magnetic resonance imaging. , 1998, Stroke.

[10]  J. Woo,et al.  Dichotomizing stroke outcomes based on self-reported dependency , 1997, Neurology.

[11]  R. Temple,et al.  Are surrogate markers adequate to assess cardiovascular disease drugs? , 1999, JAMA.

[12]  M. Moseley,et al.  Advantages of adding diffusion-weighted magnetic resonance imaging to conventional magnetic resonance imaging for evaluating acute stroke. , 2000, Archives of neurology.

[13]  H. Ellis stroke , 1997, The Lancet.

[14]  W. Mali,et al.  Diffusion-weighted magnetic resonance imaging in acute stroke. , 1998, Stroke.

[15]  T. S. Olsen Outcome following occlusion of the middle cerebral artery , 1991, Acta neurologica Scandinavica.

[16]  K. Muir,et al.  Neuroprotection for acute stroke: making clinical trials work. , 1999, Stroke.

[17]  C. Beaulieu,et al.  Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: Evolution of lesion volume and correlation with clinical outcome , 1999, Annals of neurology.

[18]  Multicentre Acute Stroke Trial—Italy Group Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke , 1995, The Lancet.

[19]  M Fisher,et al.  New magnetic resonance techniques for acute ischemic stroke. , 1995, JAMA.

[20]  J. Zivin Diffusion‐weighted MRI for diagnosis and treatment of ischemic stroke , 1997, Annals of neurology.

[21]  P D Lyden,et al.  Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study Group. , 1999, Stroke.

[22]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[23]  V. L. Doyle,et al.  Middle Cerebral Artery Territory Infarction Spectroscopy and Initial Infarct Volume by MRI Predicts Outcome in Patients With Acetyl Aspartate Concentration by Magnetic Resonance N-Measurement of Initial , 1999 .

[24]  Gottfried Schlaug,et al.  Ischemic lesion volumes in acute stroke by diffusion‐weighted magnetic resonance imaging correlate with clinical outcome , 1997, Annals of neurology.

[25]  F. Mahoney,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.

[26]  B T Volpe,et al.  Middle cerebral artery stroke that includes the premotor cortex reduces mobility outcome. , 1999, Stroke.

[27]  P. Dorman,et al.  The influence of baseline prognostic variables on outcome after thrombolysis , 1999, Journal of Neurology.

[28]  S. Warach,et al.  A randomized dose-response trial of citicoline in acute ischemic stroke patients , 1997, Neurology.

[29]  R J Seitz,et al.  Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. , 1999, Stroke.

[30]  W R Clarke,et al.  Baseline NIH Stroke Scale score strongly predicts outcome after stroke , 1999, Neurology.

[31]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[32]  J Bamford,et al.  The natural history of lacunar infarction: the Oxfordshire Community Stroke Project. , 1987, Stroke.

[33]  L. Jongbloed Prediction of function after stroke: a critical review. , 1986, Stroke.

[34]  C. Aring,et al.  A CRITICAL REVIEW , 1939, Journal of neurology and psychiatry.

[35]  F. I. Mahonery Functional evaluation : Barthel index , 1965 .

[36]  V. Hachinski,et al.  Prognosis of acute stroke , 1987, Neurology.

[37]  D. Saunders,et al.  Measurement of infarct size using MRI predicts prognosis in middle cerebral artery infarction. , 1995, Stroke.

[38]  R R Edelman,et al.  Clinical Outcome in Ischemic Stroke Predicted by Early Diffusion-Weighted and Perfusion Magnetic Resonance Imaging: A Preliminary Analysis , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  T Brott,et al.  Measurements of acute cerebral infarction: lesion size by computed tomography. , 1989, Stroke.

[40]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[41]  G. Schroth,et al.  [Diffusion-weighted imaging in acute stroke]. , 1998, Der Nervenarzt.

[42]  S M Davis,et al.  Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI , 1998, Neurology.

[43]  G. Schlaug,et al.  Enlargement of human cerebral ischemic lesion volumes measured by diffusion‐weighted magnetic resonance imaging , 1997, Annals of neurology.

[44]  H. Diener,et al.  Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist. , 2000, Stroke.

[45]  M. Moseley,et al.  Yield of diffusion-weighted MRI for detection of potentially relevant findings in stroke patients , 2000, Neurology.

[46]  R R Edelman,et al.  Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke , 1997, Neurology.

[47]  J. Kucharczyk,et al.  Early detection of regional cerebral ischemia in cats: Comparison of diffusion‐ and T2‐weighted MRI and spectroscopy , 1990, Magnetic resonance in medicine.

[48]  G. Albers,et al.  Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. , 1999, JAMA.

[49]  Granger Cv,et al.  Stroke rehabilitation: analysis of repeated Barthel index measures. , 1979, Archives of physical medicine and rehabilitation.

[50]  L. Munari,et al.  RANDOMIZED CONTROLLED TRIAL OF STREPTOKINASE, ASPIRIN, AND COMBINATION OF BOTH IN TREATMENT OF ACUTE ISCHEMIC STROKE , 1995 .

[51]  S. Warach,et al.  Magnetic Resonance Imaging of Acute Stroke , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.